The effects of a somatostatin analogue on the metabolism of an infant with Beckwith-Wiedemann syndrome and hyperinsulinaemic hypoglycaemia
- 1 July 1991
- journal article
- case report
- Published by Springer Science and Business Media LLC in European Journal of Pediatrics
- Vol. 150 (9), 634-637
- https://doi.org/10.1007/bf02072623
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Activation of fatty acid oxidation in the Silver–Russell syndrome and the Brachmann–de Lange syndromeAmerican Journal of Medical Genetics, 1988
- Long-Term Treatment of an Infant with Nesidioblastosis Using a Somatostatin AnalogueNew England Journal of Medicine, 1987
- Short-Term Management of Nesidioblastosis Using the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1987
- Prolonged secretion of prolactin in response to thyrotrophin-releasing hormone after hypothalamo-pituitary disconnection in the eweJournal of Endocrinology, 1986
- Endocrine profile of a long-acting somatostatin derivative SMS 201–995. Study in normal volunteers following subcutaneous administrationActa Endocrinologica, 1986
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- Management of prolonged hypoglycaemia in Beckwith's syndromePostgraduate Medical Journal, 1977
- Growth Hormone Release Inhibiting Hormone in AcromegalyBMJ, 1974
- Metabolic aspects of the Beckwith-Wiedemann syndromeThe Journal of Pediatrics, 1973
- DISORDERS OF CARBOHYDRATE METABOLISM IN INFANCYThe American Journal of the Medical Sciences, 1966